NCT04973007 2026-04-22
Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases
University of Colorado, Denver
Phase 4 Terminated
Clinical Trials
10 trialsNCT07446465 2026-03-03
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Phase 4 Not yet recruiting
NCT06562543 2026-02-27
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Takeda
Phase 4 Recruiting
NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT07094893 2026-01-14
ARIEL-ENGIC
Gruppo Oncologico del Nord-Ovest
Phase 4 Not yet recruiting
NCT07158164 2025-11-13
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
Phase 4 Recruiting
NCT07152886 2025-09-03
The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer
The Affiliated Hospital of Qingdao University
Phase 4 Not yet recruiting
NCT07144475 2025-08-27
Comparison of Probiotic Effects on the Outcomes of Patients After Colorectal Cancer Surgery
Dharmais National Cancer Center Hospital
Phase 4 Completed
NCT07020468 2025-06-13
HOPE
Affiliated Cancer Hospital of Shantou University Medical College
Phase 4 Active not recruiting
NCT06090994 2025-05-07
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Fudan University
Phase 4 Recruiting